| JXSS2000038 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-10 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JXSS2000047 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JXSS2000046 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JXSS2000045 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JXSS2000044 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-17 | view |
| JYSB1900039 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-01-31 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-16 | view |
| JYSB1900038 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-01-31 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2021-08-16 | view |
| JYSB1900364 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2020-01-08 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2020-10-27 | view |
| JXSL2000131 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.3) | Import Drug Application | 2020-07-17 | 上海艾迈医疗科技有限公司 | 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited | In Review | 2020-07-16 | view |
| JYSB2000311 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2020-06-24 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2020-06-24 | view |
| JYSB2000301 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2020-06-22 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2020-06-24 | view |
| JXSL2000080 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2020-06-22 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2020-06-20 | view |
| JXSL2000058 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2020-05-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2020-05-23 | view |
| JXSL2000057 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2020-05-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2020-05-23 | view |
| JXSL2000056 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2020-05-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2020-05-23 | view |
| JXSL2000059 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2020-05-25 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2020-05-23 | view |
| JYSB2000087 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2020-04-03 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2020-04-07 | view |
| JYSB1900189 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-07-31 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2019-09-29 | view |
| JYSB1900188 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-07-31 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2019-09-29 | view |
| JYSB1900120 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-06-10 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2019-07-09 | view |
